Abstract-Neglected tropical diseases, especially those caused by helminths, constitute some of the most common infections of the world's poorest people. Amongst these, schistosomiasis (bilharzia or 'snail fever'), caused by blood flukes of the genus Schistosoma, ranks second only to malaria in terms of human impact: two hundred million people are infected and close to 800 million are at risk of infection. Drug screening against helminths poses unique challenges: the parasite cannot be cloned and is difficult to target using gene knockouts or RNAi. Consequently, both lead identification and validation involve phenotypic screening, where parasites are exposed to compounds whose effects are determined through the analysis of the ensuing phenotypic responses. The efficacy of leads thus identified derives from one or more or even unknown molecular mechanisms of action. The two most immediate and significant challenges that confront the state-of-the-art in this area are: the development of automated and quantitative phenotypic screening techniques and the mapping and quantitative characterization of the totality of phenotypic responses of the parasite. In this paper, we investigate and propose solutions for the latter problem in terms of the following: (1) mathematical formulation and algorithms that allow rigorous representation of the phenotypic response space of the parasite, (2) application of graph-theoretic and network analysis techniques for quantitative modeling and characterization of the phenotypic space, and (3) application of the aforementioned methodology to analyze the phenotypic space of S. mansoni -one of the etiological agents of schistosomiasis, induced by compounds that target its polo-like kinase 1 (PLK 1) gene -a recently validated drug target. In our approach, first, bio-image analysis algorithms are used to quantify the phenotypic responses of different drugs. Next, these responses are linearly mapped into a low-dimensional space using Principle Component Analysis (PCA). The phenotype space is modeled using neighborhood graphs which are used to represent the similarity amongst the phenotypes. These graphs are characterized and explored using network analysis algorithms. We present a number of results related to both the nature of the phenotypic space of the S. mansoni parasite as well as algorithmic issues encountered in constructing and analyzing the phenotypic-response space. In particular, the phenotype distribution of the parasite was found to have a distinct shape and topology. We have also quantitatively characterized the phenotypic space by varying critical model parameters. Finally, these maps of the phenotype space allows visualization and reasoning about complex relationships between putative drugs and their system-wide effects and can serve as a highly efficient paradigm for assimilating and unifying information from phenotypic screens both during lead identification and lead optimization.
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BACKGROUND
S CHISTOSOMIASIS is a helmintic disease of extreme poverty infecting over 200 million people and putting approximately 800 million people at risk across our planet. This debilitating disease has been identified as the second most socioeconomically devastating illness after malaria. Schistosomiasis in humans is caused by three major species of trematodes, Schistosoma mansoni, Schistosoma haematobium and Schistosoma japonicum. There are two basic developmental stages relevant to infection in the human; juveniles (schistosomula or somules) and adults. These differ significantly in size (0.2 versus 10 mm long), appearance, morphology, motility, and behavior (Fig. 1 ). The disease starts as an inflammatory response to the eggs of the parasites and leads to fibrotic granulomatous, causing portal vein hypertension or occlusion (intestinal schistosomiasis caused by S. mansoni) or hydronephrosis and squamous bladder cancer (urinary schistosomiasis caused by S. haematobium). Greatest infection intensities occur among children and adolescents, and mirroring the impact of other neglected tropical diseases on the affected populations [1] , [2] , schistosomiasis is known to undermine social and economic development in areas of high transmission [3] , [4] , [5] .
Currently, treatment for schistosomiasis relies on a single orally administered drug called praziquantel (PZQ) . PZQ has few side effects and demonstrates bioactivity against all the three major species infecting humans. Its success had, till recent time, stifled efforts for discovering new drugs. In spite of its advantages however, PZQ has important deficiencies in its therapeutic profile; cure rates usually vary between 60-90 percent [6] , [7] . Furthermore, the drug acts preferentially against the adult parasite, being markedly less effective (by 60-100 percent) against somules between 21 and 28 days old [13] , [14] , [15] . This decreased efficacy necessitates the retreatment of individuals harboring previously juvenile parasites and potentiates the risk for resistance by exposing (partially) refractory parasites to sub-curative doses [16] . The reliance on a single drug to treat over 200 million people also raises concerns related to the emergence of drug resistance and possible drug failure [3] , [6] , [7] . Indeed, increased parasite tolerance for the drug has been selected for in rodent hosts [8] and has been reported clinically in Egypt and subSaharan Africa [9] , [10] , [11] . The World Health Organization (WHO) has therefore declared schistosomiasis a disease for which new therapies are urgently needed [17] .
Lead Identification: Target-Based and Phenotypic Screening
In modern drug discovery, the process of lead identification involves screening a collection of chemical compounds against the target relevant to the pathology under investigation. The target could either be a molecule (typically a protein or an enzyme) critical to the disease process, entire cells or even entire organisms that are implicated in the pathology. The goal of this investigative stage is the identification of a set of compounds that show acceptable activity and are of therapeutic interest. Lead identification employs either target-based screens, using in vitro assays of individual molecules, or phenotypic screens of entire cells or organisms. In both settings, typically, a large number of molecules are screened, as even small structural variations in a compound can impact its activity against the target. Due to the need for screening large compound collections, automation and quantitative determination of efficacy is critical. Targetbased screens require prior knowledge of the target and detailed mechanism of action [34] . The output of assays in such screens is typically a measurement of the extent to which a screened compound binds to the target molecule (generally a protein or enzyme). Consequently, such screens tend to be amenable to automation. Phenotypic screens, on the other hand, are inherently holistic -that is, such screens may identify drugs whose efficacy derives from complex interactions with multiple targets, or drugs which are themselves inactive but have highly active metabolites. Furthermore, screening intact, physiological systems improves the likelihood that hits will successfully transfer to advanced stages of the drug discovery pipeline and clinical usage. Indeed, there is evidence that phenotypic assays are significantly more effective than target-based screens, and that an over-emphasis on the latter is, in part, responsible for the high attrition rates of industrial drug discovery [33] . At the same time, the very nature of phenotypic screens implies that the output is multidimensional and captures complex, time-varying changes that occur in the entire targeted system. Consequently, quantifying the efficacy of a compound vis-a-vis the target system becomes highly complicated. Due to this reason, phenotypic screens, especially for diseases such as schistosomiasis which are caused by complex multicellular parasites, are exceptionally difficult to quantify and automate.
Challenges Posed by Helminthes to the State-of-the-Art in Lead Identification Technology
In addition to the issues enumerated above, drug screening against schistosomes (and helminths in general) poses other unique challenges to the current state-of-the-art in lead identification technology. The parasite is not easily amenable to target identification using gene knockouts or RNAi, and few molecular mechanisms of host-parasite interactions are well elucidated. Being multicellular, schistosomes display complex shape-, appearance-and motion-based phenotypes that vary across drug concentration and exposure duration. Moreover, unlike model organisms like C. elegans, clones or lines of worms are not available, that is, each parasite tested in an assay is a unique individual. The ensuing heterogeneity due to genetic variability amongst the individual parasites along with the significant morphological and behavioral differences between the somule and adult stages make the task of pattern identification, characterization, and quantification very difficult (for an illustration of some of these challenges, see Fig. 1 ). Consequently, phenotypic drug screens involving helminths have been primarily manual, low-throughput, subjective, and non-quantitative. Against schistosomiasis, examples of such screens include [18] , [19] , [20] , [21] , [22] . Further, drugs such as praziquantel and artemisinin have been discovered based on this paradigm [6] . In spite of these successes, the low throughput of manual phenotypic screens constrains, both in terms of diversity and density, the exploration of the chemical space. More significantly, subjective manual evaluation compromises rigor and reproducibility. Finally, qualitative description and scoring of phenotypes limits optimization of lead compounds through rigorous quantitative structureactivity relationship (QSAR) modeling. Thus, the two immediate and most significant challenges that confront the stateof-the-art in drug discovery for schistosomiasis in particular (and helminthic diseases in general) are:
1 The research presented in this paper is directed to address the second challenge. Starting with data from phenotypic screens, we use bio-image analysis techniques developed by us to identify and quantify the phenotypic response of each individual parasite. We then propose the use of vector space mapping and linear dimensionality reduction to construct the phenotype space. A key advancement presented in this paper lies in the use of neighborhood graphs to model relationships between phenotypes in the aforementioned representation space and in the subsequent use of network analysis techniques to characterize and analyze the topology (connectivity) of this space.
PRIOR RESEARCH
Phenotypic analysis using algorithms for processing biological images has been widely employed in cell based assays [26] , [27] , [28] , [36] , [37] , [38] and for C. elegans [23] , [39] , [40] , [41] , [42] , [43] . A number of tools are available for cell segmentation and analysis, not least the CellProfiler suite [44] [45] . Other strategies for analysis of cellular phenotypes include fitting of elliptical models [46] and statistical combination of manually constructed models [47] . For C. elegans, recent methods include the use of articulated models [48] and probabilistic shape models [49] . Explicit models of size, shape and/or intensity however, are impractical for schistosomula due to the natural variation of individuals (schistosome clones do not exist) and the extreme and unpredictable effects of drug exposure. Defining priors for probabilistic models is also complicated by these very factors. Unlike C. elegans, the changes in morphology and appearance of the schistosome flatworm are far more complex and dynamic. Compared to C. elegans imaging (typically, Petri-dishes with only few worms per dish) screening and imaging schistosomes are more involved using multiple parasites in multiwell plates. For further analysis of issues discussed (including comparative experimental applying extant methods to somules), we refer the reviewer to [50] , [54] . Commercial HCS (CHCS) technology is another option that has gained popularity, especially in industrial drug discovery, for conducting cell-based phenotypic assays. CHCS technology has indeed matured for cell-based assays [51] . However, it is as yet inadequate for schistosomes. By necessity, CHCS is optimized for cell features, such as the rounded shapes of cells/ nuclei, including via fluorescent markers for feature identification and extraction. Parasitic helminths obviously differ from cells in terms of size, shape, appearance, motion characteristics and phenotypic complexity. Also, fluorescent labeling via transgenesis, for example, isn't possible. Moreover, compound action can lead to phenotypic changes that are difficult to predict and model a priori. Consequently, even basic operations such as image segmentation using HCS software, tends to be complicated and error-prone.
For bio-image analysis of helminths, a review of the prior work can be organized in terms of the development of lowlevel image analysis algorithms and higher-level algorithms that analyze data obtained from the images. The pioneering work in this area is [29] . This paper demonstrated the feasibility of automatic phenotype extraction and classification of helminths in phenotypic assays through a multi-stage process involving image segmentation for identification of individual parasites, parasite tracking, parasite representation in multivariate feature space, and finally, phenotype classification using classification and regression trees (CART). Since then rapid progress has been made in designing automated and quantitative phenotypic screening techniques, which have focused on improving individual steps in such a processing pipeline. A number of techniques of increasing sophistication have been proposed for parasite segmentation [29] , [30] , [50] . Of these, the signal-based model free Asarnow-Singh algorithm [50] has been shown to attain high segmentation accuracy (average precision 95.3 percent and average recall 94.6 percent). A variation of this algorithm using the Canny edge detector [32] led to average precision and recall rates of 96.7 and 93.5 percent respectively. Based on a multi-level parasite modeling and graph-theoretic optimization for establishment of correspondences across time, the parasite tracking algorithm proposed in [52] reported tracking individual somules with accuracies exceeding 95 percent computed across the entire video, even when there were segmentation errors in individual frames. A detailed set of shape, appearance, and motion-based descriptors were proposed for representing individual parasites in [53] .
For phenotype analysis, the use of time-series representation was proposed in [53] . This paper presented a number of algorithms for clustering and analysis of phenotypes including an algorithm for rigorously quantifying the phenotypic variability of parasite populations. Other methods for hit detection in screens using phenotype analysis include [71] , [75] . However, none of the aforementioned methods is capable of determining dose-and-time-response characteristics. The QDREC software [50] is a key recent advancement in this context. The idea of QDREC lies in the use of supervised learning to identify parasites affected by a drug at a given concentration/time point. The problem of distinguishing the affected parasites is solved by comparing the treated and control populations based on the exhibited phenotypes (described using image-based features). Given the image-based readouts from phenotypic screens, QDREC can be used to obtain dose-response curves as well as halfmaximal effective concentration (EC50) values, sort compounds by efficacy and identify leads.
Based on the progress reviewed above, both for image analysis of parasites as well as for subsequent algorithmic data analysis, it may be postulated that the challenge of developing techniques for automated and quantitative phenotype screening will soon be comprehensively met. However, little attention has been paid, as yet, to the development of algorithms for mapping and characterization of the phenotypic response space of parasites. It should be noted in this context that in mathematical biology, attempts have indeed been made to construct models of C. elegans behavior [24] , [25] . Our challenge is conceptually related, yet significantly distinct from the issues encountered in C. elegans phenotype modeling. Among others, we have to develop models of phenotypes exhibited by genetically non-homogeneous parasites and elicited in response to a number of different compounds. Thus, both the stimuli and responses we consider are significantly more complex than that encountered in [24] , [25] . Furthermore, unlike these works, our method development is dictated by the constraints and requirements of drug discovery.
METHOD
The Phenotype Response of Polo-like Kinase 1 (PLK1) Small Molecule inHibitors
For specificity and in order to keep the problem complexity manageable, in this paper, we limit ourselves to constructing and analyzing the phenotype response space of S. mansoni somules elicited by small molecule inhibitors of the S. mansoni ortholog of the human PLK1 gene. In this section, we provide a brief background to the necessary molecular biology and describe the importance of this target. The interested reader is referred to [57] for details on target validation and screening of the small molecule inhibitors. The polo-like kinases (PLKs) belong to the family of serine/threonine kinases. In humans, these molecules are involved in various aspects of cell division, including G2/M transition, centrosome maturation, formation of bipolar spindles, cytokinesis, and regulation of the spindle assembly checkpoint [55] . Five PLK genes are found in human, of these, PLK1 is the best characterized member of the family and is vital to mitotic progression. Due to its over-expression in human tumors, PLK1 is amongst the targets for developing anti-cancer drugs [56] . In S. mansoni, two PLK genes are found: SmPLK1 and SmSAK. Of these, SmPLK1 is expressed in sporocysts and in reproductive organs of the adult worms. A number of human PLK1 small molecule inhibitors are also known to inhibit SmPLK1 at nanomolar concentrations (see [57] and references therein). Furthermore, using RNA interference (RNAi), it has been shown that both SmPLK1 and to a lesser extent, SmSAK, are important to the normal development and survival of S. mansoni somules [57] .
To generate the phenotypic data, a focused set of compounds consisting of 8 commercially available human PLK1 inhibitors and 38 benzimidazole thiophene inhibitors available as part of the GlaxoSmithKline (GSK) Published Kinase Inhibitor Sets were phenotypically screened. It may be noted that the GSK benzimidazole thiophene inhibitors have completed Phase I clinical trials for treatment of solid tumor malignancies. The high-quality of these compounds was a crucial factor in our decision to use them for representing the phenotype response space of the parasite. As part of the phenotypic screening protocol for the somules, approximately 300 newly transformed parasites were dispensed into flatbottomed 96-well plates in 100 mL complete Basch medium (Corning Inc., cat. # 3599). Compound was then added in a volume of 1 ml DMSO and the final volume brought up to 200 mL with complete Basch medium. Parasites were then incubated for up to two days at 37 C under 5 percent CO2. First pass, single concentration screens at 10 mM were performed and those compounds eliciting phenotypes were then re-screened over a concentration range of 0.2-10 mM (0.5 percent DMSO). To record the phenotypes, photographic images were taken at each time point and compound concentration using a Zeiss Axiovert 40 C inverted microscope and a Zeiss AxioCam MRc digital camera controlled by AxioVision 40 (version 4.8.1.0) software.
Derivation of Ground Truth
In order to assess the drug-induced phenotypes, experts assigned ordinal scores to the parasites that were assayed. As part of this process 3,621 parasites were considered, of which 566 were controls and 3,055 were exposed to the compounds shown in Fig. 2 . The control and treated parasites were segmented with the Asarnow-Singh algorithm [50] . Each of the 3,055 images of drug treated parasite was then independently examined and scored by two experts. To insure normal biological changes were factored during phenotype assessment, five randomly selected control images from the corresponding experiment were also shown to the experts for each treated parasite image. The experts employed a Likert scale from one to three to score the somules, where a score of one implied no effect of the drug on the parasite, a score of two corresponded to mild drug effect, and a score of three implied a severe drug effect.
The Pearson correlation between the two sets of expert assigned scores was 0.67, with the experts agreeing on 1,612 of the 3,055 drug treated parasites in terms of the assigned Likert scores. A significant fraction of the disagreement between scores was confined to parasites that were considered to be unaffected by one expert and mildly affected by the other (or vice-versa). A detailed breakdown of the agreements and disagreements amongst the expert scores is shown in Fig. 3 . In the cases where the experts disagreed, for 948 parasites (65.7 percent), the Likert scores were either one or two. That is, the experts disagreed on whether the parasites were unaffected or mildly affected by the drug. For 337 parasites (23.35 percent) the experts disagreed in terms of grading the drug effects as mild or severe. Finally, for 158 parasites (10.95 percent) the expert disagreement was maximal. To ensure data quality, for subsequent phenotype analysis, we only considered the set of 1,612 parasites, for which both experts were in agreement in terms of the assigned Likert scores. For this set of parasites, the experts deemed 873 (54.16 percent) parasites to be unaffected by the corresponding drug, 266 (16.5 percent) to be mildly affected, and 473 (29.34 percent) to be severely affected.
Phenotype Extraction and Quantification
The images were segmented (i.e., individual parasites were differentiated from background) using the Asarnow-Singh segmentation algorithm. Here, we briefly describe the core ideas underlying this technique and refer the reader to [50] for details. The algorithm begins with an initial segmentation obtained by applying a global threshold to the low-pass filtered image. This approach is adapted from the region-based distributing function (RBDF) in Active Mask [31] .
Our adaptation of the RBDF has a single threshold parameter g, which is an estimator of the difference between foreground and background intensity and is computed using the Otsu algorithm. This process is described by Eqs. (1)-(3) , where $ denotes convolution, g the filtered image, c the result of the RBDF, R the segmented binary image, and h a Gaussian filter
The Asarnow-Singh algorithm employs phase congruency (PC) of the grayscale image, rather than the commonly used intensity gradient for segmentation. PC is an approach to feature detection based on a theoretical framework called the Local Energy Model (LEM) [59] . LEM postulates that perceptually salient features occur where an image's Fourier components are maximally in phase with one another. PC holds a number of advantages over the use of image gradients: first, PC is a dimensionless bounded quantity simplifying thresholding. Second, PC is illumination-and contrast -invariant, and can detect edges which do not coincide with steps in the image gradient or have arbitrary phases. Finally, PC is naturally multi-scale and can be implemented efficiently using fast wavelet transforms [60] . Consider for simplicity, a 1D intensity profile I(x). Its local energy, E(x), can be defined as shown in Eq. (4), where F(x) denotes the signal I(x) without its DC component and H(x) is the Hilbert transform of F(x). Mathematically, phase congruency can be defined as the ratio of the local energy to the sum of the Fourier amplitudes A n of I(x) (Eq. (5)). The Asarnow-Singh algorithm uses the Log Gabor wavelet transform to obtain local frequency information. In computing the PC, image features with many in-phase components receive a higher weight than those with just a few. The weights are provided by a weighting function W(x) of the local frequency spread s(x). The full PC expression including effects of noise and frequency spread is given by Eq. (6). In this equation, e is a small constant included to prevent ill-conditioned behavior and T represents a local noise estimate
The signal-driven model-free nature of the method implies that unlike model-based approaches, it can be applied, without modifications or priors, to segment any parasite regardless of the phenotypic effect elicited by a compound. When applied to the image data corresponding to the phenotypes elicited by the aforementioned 49 compounds, a total of 3,621 parasites (566 control and 3,055 drug treated) were identified across the entire study.
Once the individual parasites were separated, the phenotypes expressed by them could be captured and quantified. For this purpose, 11 descriptors were calculated for each parasite. These descriptors captured the shape, size and appearance of the parasites. Motion-based phenotypes were excluded since the phenotypes were captured using static images rather than video. Parasite shape and size were described using the following descriptors: parasite area (in pixels), length of the perimeter of the parasite, ratio of the major to the minor axis of the parasite body, ratio of the area of the parasite body to the area of its bounding box. Parasite appearance was captured through descriptors characterizing intensity and texture. The parasite intensity was described using the mean and standard deviation of the intensity distribution. Parasite texture was represented using Grey-Level Co-occurrence Matrices (GLCM), which capture how often two intensities occur side by side. The information in the GLCM was expressed using the following descriptors:
(1) energy: numerically defined as the sum of the squared elements of the GLCM, (2) entropy: representing the randomness related to the texture of an image, (3) contrast: describing the difference between the intensity value at each pixel and its neighbors assuming 8-connectivity, (4) correlation: describing the intensity correlation between a pixel and its neighbors, and (5) homogeneity: measuring the numeric similarity of the distribution of the elements in the GLCM to the distribution of the elements on the GLCM diagonal.
As a consequence of the properties characterizing shape, size, and appearance, each parasite was summarized using its corresponding 11-dimensional representation vector and represented as a point in this 11-dimensional feature space. All of our ensuing analysis was carried out on this vector space representation of the data.
Construction of the Drug-Phenotype Response Space
We seek to construct a space to represent all the elicited phenotypes of the parasites under one or more conditions. Our notion of space is that of a set of phenotypes. Algorithmically, such a notion is relatively uninteresting as it lacks structure. For instance, by itself, in such a representation we will be incapable of relating phenotypes to each other and making higher-level inferences. We therefore enrich the notion of our phenotype space by requiring that its construction endow it with a topology. Here, as in mathematics, we think of topology as information about the connectivity of a space. Thus, for each phenotype in this space, we will be able to infer the phenotypes that lie in its neighborhood (i.e., are "close" to it). To enable efficient algorithmic analysis, we also require that the phenotype representation space be low-dimensional and yet leads to minimal data reconstruction error. Starting with the vector space representation of the phenotypic data (in our case in an 11-dimensional feature space), we utilize the well-known technique of principal component analysis (PCA) to construct the low-dimensional drug-induced phenotype response space (DIPRS) while retaining the variance in the data as much as possible. In particular, we map our phenotypic data to a 6-dimensional PCA-based DIPRS, in which 95 percent of the variance in the data is accounted for (see Fig. 4 ) and where all the subsequent analysis was conducted. To enable visualization, in Fig. 4 , we show a 3-dimensional projection of the DIPRS. In this projection, each point represents a specific parasite exhibiting a particular combination of phenotypes that is (implicitly) parameterized by the concentration of the compound to which it was exposed as well as the duration of exposure. It may also be noted that the DIPRS only involved The drug induced phenotype response space (DIPRS) induced by SmPLK1 inhibitors. To facilitate visualization, the 3-dimensional projection of the DIPRS is shown with the Y-axis corresponding to the first principal component, the X-axis to the second principal component and the Z-axis to the third principal component respectively. Each point corresponds to a parasite exposed to a specific compound, concentration, and exposure duration. Intuitively, a distinct shape and topology can be attributed to the DIPRS. In the leftmost figure, the data is color coded in terms of individual compounds. In the middle figure, the effect of compounds is displayed with a heat-map with blue colors indicating no effect and red color indicating severe effects. The figure on the right also uses a heat-map to plot compound effects. However, instead of judging the effects on a per-parasite level, the experts judged the effects on an entire image level using the methodology from [57] . This figure illustrates the utility of the DIPRS as a paradigm for integrating data from different phenotypic screens as well as a tool for visual data analysis.
those parasites for which the scores assigned by both experts agreed.
Network-Based Modeling and Quantitative Characterization of the DIPRS
In this paper, we approach the analysis of the DIPRS in terms of the following issues: (1) Determining how to model the DIPRS so as to be able to characterize the phenotypephenotype relationships information present in it and (2) applying rigorous mathematical models to describe the DIPRS. To address the first issue, we need to develop models that capture the neighborhood (proximity) relationships amongst phenotypes that induce the DIPRS since these relationships define the very topology (connectivity) of each DIPRS instance. Towards this, we employ parameterized neighborhood graphs, where vertices correspond to phenotypes and neighborhood relationships are represented by connecting the corresponding vertices. The parameter of this graph captures the notion of relating parasites by similarity and acts as a threshold in determining which phenotypes can be considered proximal and which should be treated as distal. In particular, we use the family of k-nearest neighbor graph (NNG), with the parameter k characterizing each graph as described below. Consider a DIPRS V representing the n phenotypes {p 1 , p 2 , . . . p n }. Let ' k denote the NNG for scale parameter k. ' k is defined as shown in Eq. (7) 
The complete connectivity structure for V can be obtained by considering all possible k-nearest neighbor graphs as shown in Eq. (8) . The reader may note that such a representation would be multi-scale and capture the entirety of the neighborhood information present in the DIPRS
The above representation opens the possibility of analyzing V by using techniques for network analysis. In general, such an analysis is complicated due to the NP-complete nature of the underlying subgraph isomorphism problem. Consequently, network analysis methods typically rely on comparing local or global network properties to characterize the networks in question. In the following, we define the network properties used in our investigations and elaborate on the problem of finding rigorous models to characterize a DIPRS.
Overview of Global and Local Network Properties
A number of global and local properties have been proposed in literature to analyze networks. In the following, we briefly describe these and refer the reader to [61] , [62] , [63] , [64] for detailed expositions. Given a network G(V,E), common global properties include: (1) the average degree, defined as the average of all out degree of vertices in the network. A related characteristic is the degree distribution describing the probability of a node having degree d. (2) The average network diameter computed as the average of all-pair shortest paths in the network. (3) The shortest path-length spectrum describing the distribution of all-pair shortest paths. (4) The clustering coefficient, indicating the tendency of the network to have highly interconnected subsets of nodes, and (5) the clustering spectrum, defined as the distribution of average clustering coefficients of all nodes of degree d. The distribution of global properties can be used to obtain insights about the nature of the underlying network and in certain cases are mathematically well characterized. For instance, the degree distribution for Scale-free networks follows the power-law while in the case of Erd€ os-R enyi random graphs, the degree distribution is Poisson.
Unlike the global network properties described above, local network properties capture the local structural characteristics of a network and can be used to compare two networks based on such properties. One commonly used approach involves the identification of subgraphs that appear in the network much more frequently than in a random network. We use the related but different approach that employs graphlets [63] , which are small (3-5 node) connected nonisomorphic induced subgraphs to characterize the networks ' k . We (like other investigators) limit our analysis to 3-5 node graphlets because the number of graphlets on n nodes increases super-exponentially with n. Additionally graphlets even on small number of nodes have been proven to provide powerful insights about the local structural characteristics of complex networks [63] , [67] . We note that there are two possible graphlets on 3-nodes, six graphlets on 4-nodes, and twenty-one graphlets on 5-nodes, leading to a total of twenty-nine graphlets on 3-5 nodes. For an illustration of the topology of these graphlets, the reader is referred to [63] .
Modeling and Analysis of the DIPRS Connectivity
We investigate the problem of finding mathematical models that can describe V along two directions. As part of the first direction, we analyze the global characteristics of the nearestneighbor networks f k in terms of the five properties described above. The second direction involves model fitting in a generative sense. That is, we postulate that a correct (well-fitting) model would generate graphs that resemble the structure of the V being analyzed across a range of global and local network properties. We note that the question of determining such models is a fundamental one because of the following reasons: first, finding the best fitting model is self-evidently one of the most important ways to rigorously characterize a DIPRS. Second, appropriate models, once determined, can be central for comparison of phenotypes across drugs. For instance, we can determine if the DIPRS of different drugs can be characterized by the same network family or belong to different families. Third, from a theoretical modeling perspective, determination of an appropriate null model is crucial, since an inappropriate model can lead to errors, for instance, by identifying overrepresented/underrepresented subgraphs that would be ignored under a correct model. In this paper, we employ an empirical fitting strategy, where, we take different phenotypic data sets (or different neighborhood graphs by varying k) and consider a series of established network models to answer the question of finding appropriate model(s) for the data. The network models considered by us span the spectrum from classical network models, like the Erd€ os-R enyi random graph (abbreviated henceforth as ER-model) [66] to recent models like the stickiness model (abbreviated hereafter as STICKY) [65] . Additional models considered by us include: random graphs matching the degree distribution of the real-world network being analyzed (abbreviated as ER-DD) [68] , BarabasiAlbert model producing networks with scale-free degree distribution, (abbreviated henceforth as SF) [69] , and ndimensional geometric random graphs (abbreviated as GEO-nD) [70] . We determine the fit of these models to our data by computing the global and local properties of the DIPRS and comparing them with each of the aforementioned network models. Such an empirical approach is commonly used in analyzing real-world networks. However, care should be taken while interpreting the results from such an approach. This is because while the list of models considered by us includes many of the most important network models, it is possible, that a model that has not been considered may yield the best fit. Consequently, the notion of the "best" model is an empirical one and subject to the list of models considered.
Unlike comparisons based on global properties, the comparison of local properties requires the definition of an appropriate similarity measure. Recall, that graphlets quantify the local connectivity patterns of the network. Thus, a natural way to characterize a network is to consider the frequency of each of the 29 possible graphlets that can occur on 3-5 nodes. Two networks can then be compared by defining a measure on the graphlet frequency of the networks being compared. We use a measure called the relative graphlet frequency distance (RGF-distance) [67] , which is based on this idea. Given two DIPRSs D and V, the RGF distance is denoted by d RGF and is defined by Eqs. (9) and (10):
In Eq. (10), N i ðFÞ denotes the number of graphlets of type i ¼ f1; 2; . . . ; 29g and the logarithm ensures that the distance measure is not dominated by the most frequent graphlets.
EXPERIMENTS
In the following, we present a number of experiments and case studies to validate the proposed method and apply it to analyze data from phenotypic screens. The data used in our experiments was generated as described in the Method section and involved a total of 1,612 drug treated parasites and 566 control parasites. A majority of the network analysis presented subsequently was conducted using the GraphCrunch [63] software package.
Global Analysis of DIPRS Connectivity
In Fig. 5 we plot the distribution of average clustering coefficients for the nodes of each degree, the distribution of path lengths, and the degree distribution for each nearest neighbor networks w k , by varying the number of neighbors k. The change in the average degree, network diameter, and clustering coefficient of these networks, as a function of k is shown in Fig. 6 . As can be seen in Fig. 5 (I) , the distribution of the clustering coefficients remains consistent across vertices of all degrees. This suggests that the networks are evenly connected and lack any distinct central nodes or cliques. This fact is also reflected in Fig. 6 , where the plot of the clustering coefficient remains constant with increase in k. For the path length distribution, both the variance and the median become smaller as k increases, with the rate of change slowing considerably after k ¼ 5. A similar pattern is exhibited by the change in the average network diameter in Fig. 6 ; as k increases the average network diameter initially drops rapidly, before plateauing out. Together, these trends suggest that at lower k, there are many fairly disconnected sections of the graph that become connected around values of k equaling 4 or 5, at which point the network connectivity stabilizes. Finally, the average degree distribution conforms to a normal distribution as k increases, with the mean increasing linearly and the variance increasing rapidly initially before slowing down for larger values of k. In Fig. 6 , the average degree of the networks can also be seen to increase linearly, mirroring the behavior of the mean of the degree distribution. Taken together, these properties provide evidence for the hypothesis that the global network characteristics stabilize around the value of k ¼ 5.
Analysis of the Impact of Drugs on Phenotypic Diversity
The use of the DIPRS allows us to formalize the notion of phenotypic diversity: distributions that are more spread-out will be more diverse than those that are concentrated in a region of the DIPRS. Thus, we can use a statistic such as the average all-pair shortest path length (l), to characterize the phenotypic diversity of the data. In our next experiment (see Fig. 7 ), we analyzed the impact of the compounds on the phenotypic diversity by considering the change in l for the control group of parasites and those parasites that were identified by the experts as mildly or severely affected. We note that the value of l can be expected to decrease as the connectivity of the DIPRS increases with increase in the values of k. However, at any given value of k, comparative analysis of l across the aforementioned groups can be indicative of the phenotypic diversity both within these groups and across the DIPRS. We observed that the set of severely impacted parasites have, as expected, a consistently lower average all-pair shortest path distance than the controls. To explain this phenomenon, we postulate that severe drug effects impact the parasite by restricting it to a smaller region of the phenotypic space (as compared to the controls) which corresponds to the harmful phenotypes. For phenotypes corresponding to the mildly affected parasites, the distribution of l was, as expected, similar to the controls. However, the mildly affected group demonstrated a higher diversity than the controls as indicated by the values of l. Our hypothesis is that this effect is due to drugs that affect some parasites and displace them into regions of the phenotype space that are not populated by their unaffected cohort. Since the drug effects are mild, sufficient parasites continue to populate the regions of the phenotype space where the unaffected parasites reside. Consequently, take together, the diversity of the mildly affected group increases as compared to the controls and is reflected by the longer average all-pair shortest path distance for the mildly affected group of parasites.
Deriving Models of the DIPRS by Empirical Fitting Using the Difference of Clustering Coefficient
In this experiment, we employed the clustering coefficient, which is a global network characteristic, to determine which theoretical network models best describes the following key subsets of the data: (1) the controls, (2) unaffected parasites, (3) mildly affected parasites, and (4) parasites that were severely affected. The network models considered by us include the Erd€ os-R enyi random graph, random graphs matching the degree distribution of the real-world network being analyzed, the stickiness model, Barabasi-Albert model producing networks with scale-free degree distribution, and the n-dimensional geometric random graphs. To ensure that the results are not biased due to a particular choice of a critical parameter, the analysis is conducted on k-NN networks obtained across the entire range of values for the parameter k (from 1 to 10). Selected results from this experiment are graphically displayed in Fig. 8 , where the absolute difference of the data and the various models are shown on the Y-axis while the X-axis indicates the different models. The data sets that were analyzed are represented by the colored lines. For all the subsets of the data, the n-dimensional geometric random graph model (GEO) was found to be the best fitting model, with the Barabasi-Albert model producing networks with scale-free degree distribution (SF) being the second best fitting model. This result was consistent for all values of k from 4 to 10.
Model Fitting Using the Graphlet Degree Distribution
We use the graphlet degree distribution (GDD), described in the method section, to empirically fit models to our data. Unlike the network characteristics used in our analysis earlier, GDD is a local network property and consequently Green colored edges indicate a connection between parasites with similar phenotypic effects (as adjudicated by the experts) and red colored edges indicate a connection between parasites exhibiting distinct phenotypic effects. The average all-pair shortest path length for the control parasites and the parasites identified by the experts as mildly and severely affected is plotted at the bottom as a function of k. For the parasites deemed to be severely affected, a significant reduction in the average shortest path length between phenotypes was observed, implying a reduction in the phenotypic diversity for this class.
more sensitive to the local topological structure present in the data. Across all values of k and all data subsets, we found the n-dimensional geometric random graphs (GEO) to provide the best fitting model with the Barabasi-Albert model producing networks with scale-free degree distribution (SF) as the second best model. These results are graphically presented in Fig. 9 .
Comparing DIPRS Using the RGF-Distance
We examine the applicability of the RGF-distance measure to compare the DIPRS of different compounds. Intuitively for such a measure to be useful, the RGF-distance between DIPRS of compounds that elicit similar phenotypic effects should be smaller than the RGF-distance between compounds that do not have similar effects. In order to identify compounds that had similar phenotypic effects, we calculated the percentage of parasites in the three categories: no effect, mild effect, and severe effect, corresponding to each compound (see Table 1 ). From this table, it can be inferred that exposure to compounds GSK326090A (No. The RGF-distances between the DIPRS of these two trilets of compounds and the DIPRS of all other compounds was computed and is graphically presented in Fig. 10 . The RGFdistance between GSK326090A (No. 3) and GSK483724A (No. 5) was found to be significantly smaller than that between either of these compounds and GSK448459A (No. 1) for all values of k (from 2 to 10). Similarly, the RGF-distance between GSK580432A (No. 8) and either of GSK1024306A (No. 4) and GSK641502A (No. 7) was found to exceed the RGF-distance between the two latter compounds. This data provides strong empirical evidence for the applicability of the RGF-distance for comparing the similarity of DIPRS under varying conditions.
CONCLUSIONS
This paper represents a significant breakthrough towards representation and analysis of quantitative phenotypic drug screening data in context of lead identification against neglected diseases, such as schistosomiasis. We proposed a framework that draws on techniques from bio-image analysis, statistics, and network analysis to construct formal representation spaces where the phenotypic responses of the parasites can be mapped and rigorously analyzed by not only taking into account individual phenotypes but also interrelationships between phenotypes. Furthermore, the proposed Fig. 8 . Fit of different network models to the data and its subsets using the clustering coefficient. In this analysis, smaller values indicate a better fit of the corresponding model to the data. The k-NN networks were computed on the following subsets of the data: control parasites only (control), parasites that were not affected (no), mildly affected (mild), or severely affected (severe). The models considered were Erd€ os-R enyi random graph (ER), random graphs matching the degree distribution of the real-world network being analyzed (ERDD), the stickiness model (Sticky), Barabasi-Albert model producing networks with scale-free degree distribution (SF), n-dimensional geometric random graphs (GEO). As can be seen from the figure, the GEO model best fitted the data with the SF model as the second best fit. Fig. 9 . Fit of different network models to the data and its subsets using the graphlet degree distribution (larger values indicate better fit). For values of k larger than 3, the geometric random graph model (GEO) provided the best fit with the Barabasi-Albert scale-free model (SF) being the second best fit. approach can support topological and spatial reasoning about complex and multifaceted phenotypic data as well as play a significant role in unification, analysis, and visualization of data from high-throughput phenotypic screens. In this work, the ground truth was obtained based on expert analysis of the phenotypes. This is an expertiseintensive process where assessments can often differ. Ultimately, phenotypic networks are a consequence of the underlying biological networks and pathways that are impacted by drugs. Consequently, the power of the proposed framework can be realized fully through application on large networks defined on fine-grained phenotypes. To obtain such data automatically, methods such as those described in [29] have to be utilized. Another open problem involves the design of global and local network properties that are especially suited to take into account the specificities of drug-pathogen interactions.
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